Has Jung Joh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,888 in general payments to Jung Joh, MD across 388 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jung Joh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jung Joh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jung Joh, MD

Nephrology · Shoreline, WANPI 1891770533

Payments from drug & device makers

$8,888in general payments, 2019–2025

Across 388 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Amgen$875
Novo Nordisk$528
Novartis$444
GSK$401
Otsuka America Pharmaceutical, Inc.$371
plus $5K from 43 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	52	$1,409
Amgen(2 entities)	46	$875
Novo Nordisk	27	$528
Novartis	22	$444
GSK	16	$401
Otsuka America Pharmaceutical, Inc.	15	$371
Lilly USA, LLC	12	$300
Bayer	13	$283
Boehringer Ingelheim	12	$272
Dexcom, Inc.	11	$266
Sanofi-aventis U.S. LLC	13	$260
Radius Health, Inc.	7	$229
Travere Therapeutics, Inc.	13	$220
Ardelyx, Inc.	9	$215
Aurinia Pharma U.S., Inc.	5	$208
Johnson & Johnson	7	$177
Ascendis Pharma Endocrinology Inc	3	$171
Calliditas Therapeutics US Inc.	6	$155
Vifor Pharma, Inc.	9	$152
Akebia Therapeutics Inc	8	$151
Xeris Pharmaceuticals, Inc.	7	$139
Mannkind Corporation	6	$139
Lexicon Pharmaceuticals, Inc.	1	$125
Recordati_rare_diseases_inc.	5	$108
OPKO Pharmaceuticals, LLC	6	$94
Sanofi	4	$93
Ascensia Diabetes Care US Inc.	4	$87
AMAG Pharmaceuticals, Inc.	4	$82
Corcept Therapeutics	5	$76
Merck	4	$72
Medtronic(2 entities)	3	$71
Kyowa Kirin, Inc.	3	$70
Amarin Pharma, Inc.	4	$64
Otsuka Pharmaceutical Development & Commercialization, Inc.	3	$63
Averitas Pharma Inc.	2	$62
Kowa Pharmaceuticals America, Inc.	3	$62
Scpharmaceuticals Inc.	2	$60
Tandem Diabetes Care, Inc.	2	$47
Zealand Pharma US, Inc.	2	$46
Takeda Pharmaceuticals U.S.A., Inc.	2	$42
Phathom Pharmaceuticals, Inc.	1	$31
Cequr Corporation	2	$28
Insulet Corporation	1	$24
Abbott	1	$24
Cormedix Inc.	1	$20
Shire North American Group Inc	1	$20
Ionis Pharmaceuticals, Inc.	1	$20
Nxstage Medical, Inc.	1	$16
Bigfoot Biomedical Inc	1	$15

How this compares

$8,888 in reported general payments places this provider in the 90th percentile of 237 nephrology providers in Washington.

See all nephrology providers in Washington →

Medicare billing

Part B allowed, 2024

$217,964

Medicare patients

365

Services billed

1,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Shoreline

Saw Hnin MuShoreline$25K
Win KyawShoreline$7K
Bernadette ThomasShoreline$2K
Kathrine TuttleSpokane$1.9M
Osama AmroSeattle$1.4M
Jonathan JeffersonSeattle$979K
Ian de BoerSeattle$399K
Ronald ReichelEverett$365K
Nicolae LecaSeattle$344K
Dmitri VasinBremerton$215K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →